Biolife Sciences Stock Price, News & Analysis
Company Description
Biolife Sciences (OTC Link: BLFE) is a publicly traded medical instruments & supplies company in the Healthcare sector. The company has a market capitalization of $318.3K.
BLFE stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of BLFE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Biolife Sciences (BLFE) stock last traded at $0.0000. At a market capitalization of $318.3K, BLFE is classified as a micro-cap stock with approximately 3.2B shares outstanding.
Latest News
Biolife Sciences has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings. View all BLFE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BLFE Company Profile & Sector Positioning
Biolife Sciences (BLFE) operates in the Medical Instruments & Supplies industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BLFE often look at related companies in the same sector, including Tevano Systems H (TEVNF), Remedent Inc (REMI), Hear Atlast Holdings (HRAL), Wearable Health (WHSI), and Innerscope Hear (INND). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BLFE's relative position within its industry.